---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-001440"
form_type: "8-K"
ticker: null
cik: "0001318641"
company_name: "Statera Biopharma, Inc."
filed_at: "2023-01-20T23:59:59+00:00"
generated_at: "2026-06-20T12:17:21.571838+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Statera Biopharma delisted from Nasdaq; trades OTC Pink under STAB

## Summary
- Received Nasdaq delisting notice Jan 10, 2023; trading suspended Jan 12, 2023.
- Company intends to appeal to Nasdaq Listing and Hearing Review Council.
- Stock now quoted on OTC Pink (STAB); applied for OTCQB listing with no assurance.
- Nasdaq had granted continued listing subject to $1 bid and $2.5M equity by Jan 31, 2023.

## SEC filing metadata
- accession: 0001437749-23-001440
- form_type: 8-K
- cik: 0001318641
- company_name: Statera Biopharma, Inc.
- filed_at: 2023-01-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1318641/000143774923001440/0001437749-23-001440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1318641/000143774923001440/cbli20230120_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-001440
- JSON: https://secwatch.observer/filing/0001437749-23-001440.json
- Plain text: https://secwatch.observer/filing/0001437749-23-001440.txt

## Key facts
- Listing & Compliance Notices
  Statera Biopharma, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(1), 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(1), 5550(b)(2)
  source text: January 10, 2023, the Company received notice from Nasdaq that the Company’s was being delisted and that suspension of trading in the Company’s common stock will be effective at the open of business on January 12, 2023. The Company intends to appeal the delisting and request a review of the Panel’s decision by the Nasdaq Listing and Hearing Review Council. Effective January 12, 2023, the Company’s common stock is quoted on OTC Pink Open Market under the symbol “STAB”. In addition, the Company has submitted an application for trading of its common stock on the OTCQB Venture Market (the “OTCQB”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1318641/000143774923001440/0001437749-23-001440-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.